Trials / Completed
CompletedNCT04222712
A Study to Evaluate TRS01 Eye Drops in Participants With Active Non-infectious Anterior Uveitis
A Randomized, Double-Masked, Dose-Ranging Study to Evaluate the Safety and Tolerability of TRS01 Eye Drops in Participants With Active Non-infectious Anterior Uveitis.
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 16 (actual)
- Sponsor
- Tarsier Pharma · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to evaluate the safety of TRS01 eye drops in participants with active non-infectious anterior uveitis .
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | TRS01 eye drops | Dosed four times a day (QID) |
| DRUG | TRS01 eye drops | Dosed four times a day (QID) |
Timeline
- Start date
- 2020-02-01
- Primary completion
- 2020-08-24
- Completion
- 2020-08-24
- First posted
- 2020-01-10
- Last updated
- 2023-10-05
- Results posted
- 2023-10-05
Locations
2 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04222712. Inclusion in this directory is not an endorsement.